2m 2m 2m 2m 2m 2m 2m
BIOXCEL THERPTC (BTAI)
NASDAQ
$1.23-$0.03 (-2.62%)
Price as of Jun 23, 2026 7:58 PM EDT- $40.1MMarket Cap
- -27.17%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
BIOXCEL THERPTC (BTAI)
$1.23-$0.03 (-2.62%)
BTAI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.26 | ||
Change | -$0.04 (-3.08%) | ||
Open | $1.28 | ||
High | $1.32 | ||
Low | $1.25 | ||
Previous Close | $1.30 | ||
Volume | 724,363 | ||
30-Day Average Volume | 759,602 | ||
1-Week Change | 5.00% | ||
1-Month Change | 11.50% | ||
1-Year Change | -27.17% | ||
3-Year Change | -99.58% | ||
5-Year Change | -99.75% | ||
Fundamentals | |||
Shares Outstanding | 30.9M | ||
Total Assets | $34.0M | ||
Market Cap | $40.1M | ||
Enterprise Value | $123.2M | ||
Period: QTR TTM FY | |||
Revenue | $206,000.00 | ||
Net Income | -$12.7M | ||
Free Cash Flow | -$11.8M | ||
EBIT | -$9.0M | ||
EBITDA | -$8.9M | ||
Net Working Capital | -$21.1M | ||
EPS | -$0.54 | ||
Enterprise Value/EBITDA | -14 | ||
Enterprise Value/Revenue | 598 | ||
P/B | -0 | ||
P/E | -2 | ||
PEG | -0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 16 | ||
Last Split Date | 02/10/2025 | ||
Earnings & Revenue